TW223634B - - Google Patents

Info

Publication number
TW223634B
TW223634B TW080106545A TW80106545A TW223634B TW 223634 B TW223634 B TW 223634B TW 080106545 A TW080106545 A TW 080106545A TW 80106545 A TW80106545 A TW 80106545A TW 223634 B TW223634 B TW 223634B
Authority
TW
Taiwan
Prior art keywords
taxol
ring
preferred
derivative
contracted
Prior art date
Application number
TW080106545A
Other languages
English (en)
Chinese (zh)
Original Assignee
Kingston David G I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kingston David G I filed Critical Kingston David G I
Application granted granted Critical
Publication of TW223634B publication Critical patent/TW223634B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW080106545A 1991-03-18 1991-08-16 TW223634B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67043291A 1991-03-18 1991-03-18

Publications (1)

Publication Number Publication Date
TW223634B true TW223634B (enExample) 1994-05-11

Family

ID=24690379

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080106545A TW223634B (enExample) 1991-03-18 1991-08-16

Country Status (5)

Country Link
EP (1) EP0505047B1 (enExample)
JP (1) JPH0684364B2 (enExample)
AT (1) ATE137229T1 (enExample)
DE (1) DE69210078D1 (enExample)
TW (1) TW223634B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE274347T1 (de) * 1992-11-27 2004-09-15 Mayne Pharma Usa Inc Stabile injizierbare paclitaxel lösung
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
GB9705903D0 (en) 1997-03-21 1997-05-07 Elliott Gillian D VP22 Proteins and uses thereof
WO2002024179A2 (en) 2000-09-22 2002-03-28 Bristol-Myers Squibb Company Method for reducing toxicity of combined chemotherapies
AU2002239282A1 (en) 2000-11-28 2002-06-11 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
CN109890422A (zh) 2016-09-06 2019-06-14 梅约医学教育与研究基金会 紫杉醇-白蛋白-结合剂组合物及使用和制备该组合物的方法

Also Published As

Publication number Publication date
JPH0684364B2 (ja) 1994-10-26
EP0505047B1 (en) 1996-04-24
JPH0578342A (ja) 1993-03-30
ATE137229T1 (de) 1996-05-15
EP0505047A1 (en) 1992-09-23
DE69210078D1 (de) 1996-05-30

Similar Documents

Publication Publication Date Title
DE3750612D1 (de) Cc-1065 analoge.
AU7433891A (en) Electrochemiluminescent assays
DE3576331D1 (de) Tetralin-derivate, ihre herstellung und verwendung.
NO893166L (no) Makrocykliske forbindelser.
DE69023934D1 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
AU580973B2 (en) Novel polypeptides with an ``-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products
EP0690856A4 (enExample)
TW223634B (enExample)
ZA886820B (en) Steroids containing a spiro ring with 3,4 or 6 links in position 17,the process and intermediates for their preparation,their use as medicaments and the pharmaceutical compositions containing them
ATE53032T1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
ES2074148T3 (es) Nueva substancia anticancer antibiotica, su produccion y sus usos.
DE3781383D1 (de) 2,2-dimethylcyclopropancarbonsaeurederivate, die eine gesaettigte halogenierte kette an c-3 tragen, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als pestizide und sie enthaltende zusammensetzungen.
ATE59635T1 (de) 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
ATE100490T1 (de) Reaktor zur durchfuehrung von biologischen in vitro-prozessen, verfahren zur durchfuehrung eines biologischen in vitro-prozesses und verwendung des reaktors und des verfahrens.
IT1218557B (it) Processo per l'utilizzazione di materiali vegetali di scarto mediante fermentazioni aerobiche controllate precedute da pretrattamenti chimici
RU94027006A (ru) Способ получения 4-(гидроксиалкил)фенолов
ES2007239A6 (es) Sistema de reciclaje de purines.
GB2011410A (en) Pyrido[1,2-a]Pyrimidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them
DE3880348D1 (de) N-substituierte alpha-mercaptomethylbenzenpropanamid-derivate, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
NO902881D0 (no) Fremgangsmaate for fremstilling av en s-2,2-r1,r2-1,3-dioksolan-4-metanol.
JPS646275A (en) Mitomycin derivative
Greenberger et al. Characterization of Bone Marrow Stromal Cells
SE8703641D0 (sv) Phosphorylated acylglycosides, their preparation and use
HU896187D0 (en) Process for activ sludge purification of sewege-water containing biologically decomposing toxic substances by determination of the most convenient reactor type and reactor arrangment
GB2289678A (en) Cell support structures